6 Results for "

SF-539

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "SF-539" in MCE Product Catalog:

  • Targets Recommended:
Cat. No.: HY-155271
Target:  

Carbonic Anhydrase

Research Areas:  

Others

hCAXII-IN-7 (compound 6e) is a hCA XII inhibitor. hCAXII-IN-7 has BBB permeability. hCAXII-IN-7 induces 786-0, SF-539 and HS 578 T cells apoptotic .
loading...
    loading...
Cat. No.: HY-151592
CAS No.: 2977251-00-4
Target:  

Antibiotic

Research Areas:  

Cancer

Anticancer agent 91 is a benzothiazole-2-thiophene S-glycoside derivative with antitumor and antiviral activity. Anticancer agent 91 has high inhibition against the two cell line from CNS cancer (SF-539 and SNB-75) .
loading...
    loading...
Cat. No.: HY-151589
CAS No.: 2977251-02-6
Target:  

Virus Protease

Research Areas:  

Infection Cancer

HCVcc-IN-2 is a benzothiazole-2-thiophene S-glycoside derivative with antitumor and antiviral activity. HCVcc-IN-2 has high inhibition against the three cell line from CNS cancer (SF-539 and SNB-75), colon cancer (HCT-116), and renal cancer (A498) .
loading...
    loading...
Cat. No.: HY-146230
CAS No.: 2439096-06-5
Target:  

VEGFR

Research Areas:  

Cancer

VEGFR-2-IN-26 (compound 5h) is a highly potent VEGFR-2 inhibitor with an IC50 value of 15.5 nM. VEGFR-2-IN-26 has good antiproliferative activity against the leukemic, non-small lung, CNS, ovarian, renal, prostate and breast cancer cells .
loading...
    loading...
Cat. No.: HY-163629
CAS No.: 3040033-95-9
Target:  

Drug Derivative

Research Areas:  

Cancer

Anticancer agent 224 (Compound 16) is an anticancer agent that can effectively inhibit the growth of central nervous system (CNS), kidney and breast cancer cell, with a GI50 value ranging from 0.6 to 12.8 μM .
loading...
    loading...
Cat. No.: HY-175245
Target:  

Carbonic Anhydrase

Research Areas:  

Cancer

hCA-IN-1 (Compound 5u) is an hCA inhibitor with Ki values of 159.2, 4.8, 15.5, and 2 nM against hCA I, hCA II, hCA IX, and hCA XII, respectively. hCA-IN-1 exhibits broad-spectrum anticancer activity against melanoma, breast, and colon cancer cells. ADME predictions indicate that hCA-IN-1 has good solubility and oral bioavailability. hCA-IN-1 can be used in tumor research .
loading...
    loading...